Click image to enlarge
The V-PLEX SARS-CoV-2 Panel 32 (IgG) Kit is a multiplex serology assay for antibodies to Spike antigens from the Omicron variant of SARS-CoV-2. It includes antigens from several emerging Omicron sublineages, including XBB.1, BF.7, BQ.1, BQ.1.1, BA.4.6, and BA.2.75.2. Panel 32 includes: A (WT), (B.1.1.529; BA.1; BA.1.15), (BA.2.75), (BA.2.75.2), (BA.4.6), (BA.5), (BF.7), (BQ.1), (BQ.1.1), and (XBB.1).
-
-
Specifications
-
Kit Contents
-
Documentation
-
References
|
Analyte(s)
|
|
SARS-CoV-2 Spike, SARS-CoV-2 Spike (B.1.1.529; BA.1), SARS-CoV-2 Spike (BA.2.75), SARS-CoV-2 Spike (BA.2.75.2), SARS-CoV-2 Spike (BA.4.6), SARS-CoV-2 Spike (BA.5), SARS-CoV-2 Spike (BF.7), SARS-CoV-2 Spike (BQ.1), SARS-CoV-2 Spike (BQ.1.1), SARS-CoV-2 Spike (XBB.1)
|
|
|
Species
|
|
Human
|
|
|
Instrument(s)
|
|
SECTOR Imager 2400
,
MESO QuickPlex SQ 120MM
,
MESO SECTOR S 600
,
SECTOR Imager 6000
,
MESO SECTOR S 600MM
,
MESO QuickPlex SQ 120
|
|
|
Plate Type
|
|
96-well
|
|
|
Sample Type
|
|
Serum, Plasma, Saliva, Upper Respiratory Sample
|
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
|
Storage Condition
|
|
Multi-Component
|
|
|
Schedule B Code
|
|
3822.19.0000
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
Serology Control 1.1
|
≤-70 °C
|
1 vial
(1 mL)
|
|
|
|
Serology Control 1.2
|
≤-70 °C
|
1 vial
(1 mL)
|
|
|
|
Serology Control 1.3
|
≤-70 °C
|
1 vial
(1 mL)
|
|
|
|
Reference Standard 1
|
≤-70 °C
|
1 vial
(1 mL)
|
|
|
|
|
2-8 °C
|
1 vial
(5 plate size)
|
|
|
|
SARS-CoV-2 Plate 32
|
2-8 °C
|
5 each
(1 each)
|
|
|
|
|
2-8 °C
|
1 bottle
(1000 mL)
|
|
|
|
|
RT
|
1 bottle
(90 mL)
|
|
|
|
|
RT
|
1 bottle
(100 mL)
|
|
|
|
MSD Blocker A
|
RT
|
1 bottle
(250 mL)
|
|
|
|
MSD Phosphate Buffer
5X
|
RT
|
1 bottle
(50 mL)
|
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
Serology Control 1.1
|
≤-70 °C
|
5 vial
(1 mL)
|
|
|
|
Serology Control 1.2
|
≤-70 °C
|
5 vial
(1 mL)
|
|
|
|
Serology Control 1.3
|
≤-70 °C
|
5 vial
(1 mL)
|
|
|
|
Reference Standard 1
|
≤-70 °C
|
5 vial
(1 mL)
|
|
|
|
|
2-8 °C
|
5 vial
(5 plate size)
|
|
|
|
SARS-CoV-2 Plate 32
|
2-8 °C
|
25 each
(1 each)
|
|
|
|
|
2-8 °C
|
5 bottle
(1000 mL)
|
|
|
|
|
RT
|
5 bottle
(90 mL)
|
|
|
|
|
RT
|
5 bottle
(100 mL)
|
|
|
|
MSD Blocker A
|
RT
|
5 bottle
(250 mL)
|
|
|
|
MSD Phosphate Buffer
5X
|
RT
|
5 bottle
(50 mL)
|
|
|
|
Product Inserts
|
|
|
|
Handouts
|
|
|
|
Certificate of analysis
|
|
|
|
SDS
|
|
|
|
Title
|
Journal
|
Year
|
|
IgG Anti-Spike Antibodies and Surrogate Neutralizing Antibody Levels Decline Faster 3 to 10 Months After BNT162b2 Vaccination Than After SARS-CoV-2 Infection in Healthcare Workers
|
|
|
|
Immune responses after omicron infection in triple-vaccinated health-care workers with and without previous SARS-CoV-2 infection
|
|
|
|
Performance and validation of an adaptable multiplex assay for detection of serologic response to SARS-CoV-2 infection or vaccination
|
|
|
|
Quantitative serology for SARS-CoV-2 using self-collected saliva and finger-stick blood
|
|
|
|
Sensitive Serology Measurements in the Saliva of Individuals with COVID-19 Symptoms Using a Multiplexed Immunoassay
|
|
|
|
|
View All
|
Order Details
Catalog No
Size
Price in USD
Qty
Customer Service/Orders
Scientific/Technical Support
Instrument Support
Company Headquarters